Antimuscarinics for extrapyramidal side-effects (Formulary: CNS)

Antimuscarinic drugs reduce the symptoms of drug-induced Parkinsonism, although tardive dyskinesia is not improved and may be worsened. They do not improve akathisia unless associated with stiffness. Assess the need for antimuscarinic drugs after 3 months of treatment. These drugs have the potential for misuse and careful review of some patients’ motivation in asking for them is required. Antimuscarinic drugs are known to have an effect on cognition, particularly in the elderly.

For the treatment of acute dystonic reactions and oculogyric crisis see: Rapid tranquilisation (Guidelines) | Right Decisions for alternative anticholinergic injection choices.

03/10/25: Procyclidine solution for injection 10mg/2mL has been discontinued.  For advice on alternative injectable anticholinergics see: Discontinuation of Procyclidine 10mg/2ml solution for injection ampoules – SPS, and the NHS Highland Medicines shortage log (NHS Highland intranet access required)

PROCYCLIDINE

Important: Therapy notes

Important: Formulation and dosage details

Formulation:

Tablets 5mg

Dosage:

As per:

Older people, preferably lower end of range. When stopping reduce stepwise to the minimum effective dose.

Important: Formulation and dosage details

Formulation:

Syrup 2·5mg/5mL

Dosage:

As per:

Older people, preferably lower end of range. When stopping reduce stepwise to the minimum effective dose.

Editorial Information

Version: 2

Document Id: F103